TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Top Trader Explains Why Stocks Had Worst Day of 2017
Play
MARKETS

Dow Lower as Wall Street Preps for an Eventful Week

  • By Joseph Woelfel
  • Dec 9, 2019 5:14 PM EST
Top Trader Explains Why Stocks Had Worst Day of 2017
MARKETS

Dow Lower as Wall Street Preps for an Eventful Week

  • By Joseph Woelfel
  • Dec 9, 2019 5:14 PM EST
Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
INVESTING

Merck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 Billion

  • By Martin Baccardax
  • Dec 9, 2019 9:47 AM EST
Biogen Wins a Battle, Not the War Against Alzheimer's
INVESTING

ArQule Jumps on Positive Phase 1 Blood Cancer Trial Results

  • By Tony Owusu
  • Jun 14, 2019 10:31 AM EDT
Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

Insider Trading Alert - SUMR, CVO And ARQL Traded By Insiders

  • By TheStreet Wire
  • Dec 21, 2015 12:16 PM EST
Trade-Ideas: MetLife (MET) Is Today's Post-Market Leader Stock
MARKETS

Insider Trading Alert - ARQL, MTSC And PFNX Traded By Insiders

  • By TheStreet Wire
  • Dec 18, 2015 10:45 AM EST
New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Insider Trading Alert - SAVE, ARQL And THST Traded By Insiders

  • By TheStreet Wire
  • Dec 17, 2015 2:00 PM EST
New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Insider Trading Alert - ORM, OLBK And ARQL Traded By Insiders

  • By TheStreet Wire
  • Dec 15, 2015 12:30 PM EST
Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

Insider Trading Alert - TIPT, RDNT And ARQL Traded By Insiders

  • By TheStreet Wire
  • Dec 14, 2015 10:45 AM EST
3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Insider Trading Alert - ITG, CDXS And ARQL Traded By Insiders

  • By James Giaquinto
  • Nov 21, 2014 2:45 PM EST
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

4 Biotech Stocks Under $10 to Watch for Breakout Trades

  • By Roberto Pedone
  • Jun 20, 2014 8:27 AM EDT
5 Stocks Under $10 Set to Soar
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • May 22, 2014 2:33 PM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

3 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • May 16, 2014 8:40 AM EDT
Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

10 ASCO '13 Abstracts You Can Read Right Now

  • By Adam Feuerstein
  • May 15, 2013 6:00 PM EDT
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Under-$10 Stocks Setting Up to Trade Higher

  • By Roberto Pedone
  • Nov 30, 2012 12:14 PM EST
5 Stocks Insiders Love Right Now
INVESTING

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Oct 26, 2012 1:24 PM EDT
Investing Ahead of Earnings: Lennar, Nike and Tiffany
MARKETS

Dow Closes Lower; Nasdaq, S&P 500 Edge Up

  • By Andrea Tse
  • Oct 2, 2012 4:47 PM EDT
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Arqule Shutters Lung Cancer Study Early Due to Futility

  • By Adam Feuerstein
  • Oct 2, 2012 7:55 AM EDT
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Arqule Shares Slide on Lung Cancer Drug Safety Concern

  • By Adam Feuerstein
  • Aug 29, 2012 10:15 AM EDT
ASCO 2012 Live Blog -- Saturday
INVESTING

ASCO 2012 Live Blog -- Saturday

  • By Adam Feuerstein
  • Jun 2, 2012 7:02 AM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

22 Biopharma Stocks With Breakout Potential in 2012

  • By Adam Feuerstein
  • May 22, 2012 8:56 AM EDT
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)

  • By Adam Feuerstein
  • May 17, 2012 6:19 AM EDT
Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

ASCO '12 Abstract Dump: Cancer Stocks in Focus

  • By Adam Feuerstein
  • May 16, 2012 6:00 PM EDT
5 Stocks Insiders Love Right Now
INVESTING

3 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Apr 3, 2012 12:42 PM EDT
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

7 Cancer Drug Stocks to Know Right Now

  • By Adam Feuerstein
  • Mar 14, 2012 9:55 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.